Unitree falls about 45% from its post-IPO peak as humanoid valuations face a reality check

Unitree did not suddenly stop building capable robots. Something else changed: the market started testing the price of the narrative. After an extreme IPO, investors are asking how much commercial deployment and profit sits behind the humanoid boom.

From a 460% debut jump to a roughly 45% drop from the peak

Reuters reports that Unitree shares finished their debut up 460%, with the company’s valuation reaching about $66 billion at the peak. The stock then declined for three consecutive sessions, losing roughly 45% from post-debut levels and erasing around $30 billion of market value.

That is extreme volatility even for a hot technology segment. It does not directly tell us whether G1, H1 or H2 are good robots. Equity markets price future cash flows and investor expectations, not the quality of an individual demonstration.

Fundamentals are receiving more scrutiny

Reuters cites Unitree’s prospectus showing adjusted net profit down 53% year on year to RMB 40 million in Q1 2026. At the same time, Unitree is one of China’s largest quadruped and humanoid manufacturers and its robots have extraordinary media visibility.

The question is the gap between technology visibility and commercial use. Investors are beginning to ask about industrial customer mix, repeat orders, margins, service and productivity. That is a healthy shift because running, dancing and martial-arts demos do not by themselves create deployment economics.

This is not proof that the “humanoid bubble has burst”

Reuters quotes investors warning about inflated valuations and weaknesses in China’s IPO mechanism, but also fund managers comparing robotics with the early EV market. Both perspectives have merit: current profit may understate future scale, but future scale is not guaranteed.

RoboMorrow therefore avoids declaring that the bubble has burst. A more precise conclusion is that the market has begun testing how much it is willing to pay for the humanoid narrative before broad, repeatable deployments and stronger fundamentals arrive.

What it could mean for other humanoid companies

If the correction changes investor behavior, future robotics companies may need to communicate contracts, shipment volumes, revenue and reliability more aggressively. For Figure, XPENG, UBTECH, Agility and younger Chinese startups, that could mean a smaller premium for simply being “a humanoid company” and a larger premium for proven deployment.

That shift would be useful for customers. Over time capital should reward products that solve real workflows, have service support and generate measurable ROI. That is the same framework used in the RoboMorrow Humanoids 2026 Buying Guide.

What it means for Poland and Europe

The direct effect on Polish customers is limited. Unitree continues to sell robots, and its share price does not automatically change store pricing. Indirectly, however, a broader repricing of robotics could affect capital availability and the pace of international expansion.

For European buyers the practical lesson is simple: brand popularity and startup valuation do not replace product due diligence. CE documentation, parts, service, software, SLA and evidence of autonomy in the target workflow still matter more.

Sources and methodology

Independent source: Reuters, Aug. 25, 2026. Share-price and prospectus figures are reported by Reuters. RoboMorrow does not treat the stock correction as evidence for or against the quality of specific Unitree robots and does not provide investment advice.

Why a share price is not a robot benchmark

Equity markets price expectations about future revenue, margins, risk and interest rates; they do not directly measure how fast a robot walks or how well it manipulates an object. After a 460% first-day surge, a large correction can partly reflect normalization of extreme momentum. RoboMorrow therefore will not use the share-price decline as evidence that Unitree’s technology suddenly became worse.

The market may, however, start forcing healthier questions. How many robots are doing sustained customer work versus going to laboratories and education? What are margins after service costs? How much revenue comes from humanoids rather than other products? How many deployments run for thousands of hours without frequent intervention? A mature industry needs those metrics if valuations are to rest on more than narrative growth.

A valuation reset could be healthy for the sector

If investors begin rewarding companies that publish repeatable business outcomes and hard operating KPIs rather than only viral demonstrations, humanoid makers will have stronger incentives to disclose reliability, cost and productivity data. That would also help European buyers. Unitree’s current move is not enough to declare that a robotics bubble has burst, but it is a clear reminder that even the most visible robotics companies will eventually be judged by deployment economics.

What this changes for a robot buyer

For an industrial customer, a supplier’s share price matters mainly as one signal of its ability to fund service, R&D and expansion; it does not replace product due diligence. Spare-part availability, warranty, service response time, APIs, safety documentation and references from similar environments remain more important. A high market capitalization guarantees none of those things, just as a falling share price does not automatically make the robot less competitive.

RoboMorrow will therefore track Unitree on two separate axes: technology and deployment on one side, business health and valuation on the other. Combining those perspectives is more useful than a simple “success” or “bubble” narrative.